| • Implement primary and secondary prevention of stroke; primary prevention applies to all patients. Patients who experienced a stroke should be treated according to secondary prevention guidelines. |
| • No evidence base to support application of secondary stroke prevention treatment strategies for WMH alone. |
| • Individualized approach to initiate or modify antithrombotic agents based on weighing the individual patients estimated absolute risk of future ischaemic or haemorrhagic events. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.